 |
Summary of Animal Studies
of PCBs and Lung Cancer
(Each entry represents one finding in a study. Some
studies had multiple findings.)
-
PCB treatment of newborns increased the cancer-causing ability
of a tobacco chemical in one strain of mice but not in another
-
PCB treatment of newborns increased the cancer-causing ability
of NNK (a tobacco chemical) in one strain of mice but not in another
-
the fetus may face increased cancer risks when exposed (through
the mother’s exposure) to chemicals which induce enzymes which metabolize
other chemicals to become carcinogenic.
-
metabolism of aromatic carcinogens appears early in gestation
and is highly inducible transplacentally in rodents by chemicals such as
dioxin, resulting in dramatic percent increases in enzyme activity
-
the fetus may be much more sensitive than adults
-
PCBs promote NDMA (tobacco chemical) initiated lung tumors
after a single dose
-
average tumor numbers were enhanced 4-fold
-
nonmetabolized PCB congeners retained in the tissues continuously
stimulated tumor growth
-
PCBs alone produced a slightly significant increase of tumors
in newborns
-
PCBs administered after NDMA initiation in newborn mice resulted
in a substantial increase in lung tumors
-
sequential exposure to PCBs and tobacco chemicals may result
in increased tumor yield, but with chemical-, sex-, and age-dependent differences
-
significant lung tumors developed in male fetuses exposed
to NNK or NDMA (tobacco chemicals), followed by exposure after birth to
PCB Aroclor 1254.
-
exposure to NDMA in the womb yielded no tumor increase unless
further exposed to PCB Aroclor 1254, when 36% developed lung tumors
-
later PCB exposure doubled the incidence of lung tumors in
newborn mice exposed to NDMA
-
PCB effects depend on the timing of PCB exposure and sex
-
single doses of PCBs into the digestive system were enough
to cause the lung cancer effect
-
PCBs (Aroclor-1254) were used to induce enzymes which facilitated
the mutagenicity of small particulates, which may contribute to the induction
of lung cancer
-
depletion of vitamin-A in the lung increases susceptibility
to lung cancer
-
pentachlorophenol (usually contaminated with dioxins) was
associated with airborne particulate matter which was associated with depletion
of vitamin-A [PCBs are also usually contaminated with dioxins)
-
PCBs play a role in levels of cytochrome-P450 enzymes in
the lungs
-
the lung enzyme, cytochrome P450 1A1, was significantly increased
by PCBs
-
cytochrome P450 IIB1 was significantly elevated
-
total PCB lung content decreased with half lives of 17 and
9 weeks
-
lower chlorinated PCBs cleared more rapidly that highly chlorinated
compounds
-
regulation of lung enzymes following PCBs involves interactions
between specific PCB congeners
-
the Ah receptor is not involved in PCB suppression of the
lung enzyme, cytochrome CYP2B
-
regulation of the lung enzyme, cytochrome CYP1A1, does appear
to involve the Ah receptor
-
PCBs decreased the cytochrome P4502B by about 50-60% in both
strains of mice
-
kidneys are more sensitive than lungs to PCB enzyme induction,
but the effect is more persistent in lungs
-
PCB Aroclor 1254 was a potent enzyme inducing agent in the
lungs
-
mutational activation of the K-ras oncogene often occurs
in human and mouse lung adenocarcinomas
-
PCBs caused an increase in membrane/cytosol ratio in mouse
lungs
-
PCBs and dioxins can induce the K-ras p21 oncogene [cancer
gene] or increase its membrane level in certain mouse strains, but these
properties are not fully dependent on Ahr receptor type
-
K-ras p21 induction may be related to lung cancer
-
HPOP and BOP (two tobacco carcinogens) required the presence
of lung enzymes induced by PCBs in order to show positive mutagenic activity
-
lung abscesses and pneumonia have been observed in mammalian
species exposed to PCBs
-
a uteroglobin lung protein has been identified which, although
not a receptor, has served to specifically concentrate methylsulfone metabolites
of PCBs in lung Clara cells
-
enzymes induced by PCBs increase the mutagenicity of nitrosamines
-
PCBs and dioxin together increased the incidence of lung
and palate/nasal turbinates or tongue cancer in both sexes
-
respiratory tract biotransformation of many man-made toxic
chemicals found in inhaled environmental pollutants is generally considered
essential for the mutagenic, carcinogenic, and/or toxic response of lung
tissue to these chemicals.
-
mouse lung tissue enzymes induced by PCBs were used to test
metabolic behavior of several toxic compounds
-
PCB induced enzymes help promote mutations induced by cigarette
smoke condensate
-
metabolic activation is required before NNK (a tobacco chemical)
will induce lung tumors
-
PCBs induce the enzyme (cytochrome P450) which metabolically
activates NNK
-
PCBs were used to stimulate lung enzymes used to test whether
a class of chemicals caused mutations
-
PCBs strongly stimulated the activity of the NADPH-requiring
enzymes responsible for ICR deactivation, which may relate to lung cancer.
-
PCBs are a weak inducer of aryl hydrocarbon hydroxylase (AHH)
activity in rabbit lung
-
Furans caused a 3-fold increase in AHH activity in the lung
[PCBs are generally contaminated furans.]
-
PCB and furan pretreatments caused a greater than 15-fold
and about 3- to 4-fold increase in the formation of the tumor-causing metabolites
-
PCBs caused a 75% decrease in formation of K-region metabolite,
BP-4, 5-deydrodiol
-
NNK (a tobacco chemical) required bioactivation by enzymes
in order to cause mutations (which might lead to cancer)
-
PCBs were used to induce enzyme production which led to this
bioactivation
-
PCBs combined with main-stream and side-stream cigarette
smoke condensates to induce AHH activity in the lung
-
one lung lesion with adenoma (cancer) was induced by PCBs
in a small test population of mice
-
PCB may promote (but not initiate) lung tumors induced by
1-nitropyrene
-
PCB may not induce K-ras mutation directly
-
when both PCBs and 1-nitropyrene (a pollutant) were present
both the number and size of tumors were significantly more
-
thymidine incorporation into lung DNA was significantly increased
by PCB injection
-
PCBs reduced DNA I-compounds, which may correlate with lung
cancer
-
2 PAH’s [air & water pollutants] caused increased mutations
and increased DNA adduct levels if the test included lung microsomes from
PCB-treated animals
-
PCB pretreatment inhibited (S)-nicotine oxidation
-
Clara cells of the bronchiolar epithelium and Type II cells
of the alveolar epithelium are possible target cells in lung cancer
-
PCB feeding did not consistently change oxygen utilization,
phagocytic activity or microbicidal activity in phagocytic cells.
-
certain individual parameters were altered by PCBs, but not
in any temporal pattern.
-
fibronectin, a surface binding glycoprotein, was significantly
decreased
-
certain PCB types did not increase tumor susceptibility in
a certain mouse strain
-
a certain protein in lung fluids binds selectively to certain
PCB metabolites, causing PCB accumulation in the lung
-
the toxicological significance of this behavior is unknown
-
PCBs caused proliferation and dilation of agranular endoplasmic
reticulum throughout the apical cytoplasm of Clara cells in the lung
-
ciliated cells were unaffected
-
such PCB doses did not induce severe bronchiolar lesions
in mice
-
a certain protein in lung fluids binds selectively to certain
PCB metabolites, causing PCB accumulation in the lung
-
the protein was localized in the secretory granules of the
apical Clara cell cytoplasm
-
the protein plays an important role in determining the in-vivo
disposition of PCBs.
-
dioxin increases the induction of enzymes in the lung, which
alters the reactivity of certain air pollutants in the lung [PCBs are frequently
contaminated with dioxins, and certain PCBs are dioxin-like]
-
PCB binding protein is synthesized in or secreted from Clara
cells.
-
studies of PCBs and lung toxicity should take methylsulfonyl
PCBs into consideration.
-
the PCB binding protein in the lung has been specifically
identified
-
Clara cell secretory protein may mediate the biological accumulation
of potentially harmful PCB metabolites in the lung
-
Clara cells contain a secretory protein of molecular weight
12800d that specifically binds PCB methyl sulfones with high affinity
-
this protein plays an important role in the in-vivo disposition
of these compounds
-
PCBs accumulate and are retained longterm in the lungs’ tracheobronchial
mucosa
-
the PCB-binding protein complex has been shown to be subsequently
secreted into the airway lumen and spread over the entire surface lining
-
a structural relationship exists between the rat lung PCB
binding protein and uteroglobin, a hormonally regulated steroid binding
protein in rabbit lung
-
certain PCB metabolites accumulate strikingly in rat lung
tissue, due to a uteroglobin-like macromolecule in the lung
-
immunological alteration may be different between peripheral
blood and respiratory system as one of the target organs of PCBs and furans
-
PCB pretreatment did not alter the 50% lethal dose of 1-nitronaphthalene
-
PCB did prevent morphological signs of lung injury and any
increase in either lung weight or enzyme activity in bronchoalveolar lavage
fluid
-
PCBs made liver injury worse
-
both lung tumor incidence and multiplicity were significantly
increased when mice exposed to environmental cigarette smoke were pretreated
with PCBs, as compared to exposure only to environmental cigarette smoke
-
PCB 52 and its oxide failed to induce lung cancer
-
three P-450 enzymes induced by PCBs in rat lungs are involved
in the activation of several procarcinogens such as polycyclic aromatic
hydrocarbons [combustion byproducts]
-
two PCBs produced greater lung enzyme activity than they
did liver enzyme activity
-
PCBs produced increases of two to five times control levels
-
relative induction potency of PCBs appears to be tissue specific
and EROD activity may not accurately reflect potency in non-liver tissues.
-
Dioxin Toxic Equivalency Factors (TEFs) proposed for PCBs
may overestimate potencies by factors of ten to 1000.
-
rates of individual BaP metabolite production are increased
in lungs from mice pretreated with PCBs
-
the existence of significant cytochrome P-450-dependent and
conjugative BaP metabolism in the intact mouse lung is supported, similar
to that examined in other species, and capable of contributing to the systemic
metabolism of this carcinogen.
-
PCBs are used to induce drug-metabolizing enzymes
-
PCBs are very good inducers of AHH enzyme activity in certain
mouse strains
-
strain of mouse and type of tissue are important variables
in assessing the potential effect of microsomal enzyme-inducing PCBs on
the metabolism of mutagenic substances.
-
PCB induced enzymes enhanced the mutagenicity of 3 metabolites,
but decreased mutagenicity of other metabolites
-
PCB induced enzymes increased the mutagenic response due
to several common air pollutants
-
conversion of certain procarcinogens to active mutagens occurred
only in the presence of enzymes
-
enzymes induced by dioxins and PCBs strongly increased mutagenic
activity of aromatic amines
-
dioxin induced activity was higher than that of PCBs
-
pretreatment of rats with PCBs markedly induced reductase
(enzyme) activity in livers
-
the effect in lungs was 6% of the effect in livers
-
PCBs traveled to the lungs and other organs after injection
intraperitoneally, though less than to the liver and kidneys
-
PCB induced enzymes caused a noticeable accumulation of two
common carcinogens in the lungs’ alveolar region
-
irreversible binding in lung tissue was present in endothelial
cells of arteries and veins, in the alveolar septal walls, and in type
2 pneumocytes
-
PCB pretreatment enhanced the metabolic activation of 4-nitroquinoline
diaphorase in the lung, leading to possible disorders in steroid homeostasis
and cancer
-
PCB induced enzymes converted a non-mutagenic chemical (phenanthridine)
into a mutagenic one.
-
the number of tobacco-initiated lung tumors in newborn mice
were increased by PCBs 2.5-fold at 28 weeks, and fourfold at 28 and 52
weeks.
-
PCBs promote lung tumors by triggering the early appearance
of tumors which would otherwise occur in old age.
-
Clara cell specific protein (CC10), also known as a PCB (a
potent carcinogen)-binding protein, may be related to lung cancers
PCB enzyme induction will be used to test the metabolic
activation of two lung carcinogens
Go to:
The
Animal Studies 1 - 31
The
Animal Studies 32 - 32
Upcoming
Research
Studies
Without Abstracts
Links
to More Information
References

|